Mechanisms and quantification of adsorption of three anti-inflammatory pharmaceuticals onto goethite with/without surface-bound organic acids

Nowadays non-steroidal anti-inflammatory drugs (NSAIDs) are often detected in surface water and groundwater. In this study, effects of environmental factors, i.e., solution pH, ionic strength, temperature and surface-bound organic acids, on bonding of three typical NSAIDs (ketoprofen, naproxen and diclofenac) onto goethite were systematically investigated. Column chromatography, batch experiments, attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy and surface complexation modeling were used to probe the adsorption mechanisms. Bonding of three NSAIDs onto goethite was totally reversible, ionic strength-dependent and endothermic (adsorption enthalpy 2.86-9.75 kJ/mol). These evidences supported H-bonding mechanism, which was further explained by ATR-FTIR observation and a triple planes model. Surface-bound organic acids (phthalic acid, trimellitic acid and pyromellitic acid) by inner-sphere complexation with goethite were hard to be desorbed. Surface-bound phthalic acid increased the uptake of NSAIDs but surface-bound trimellitic acid and pyromellitic acid reduced their adsorption. The reason is that the adsorbed phthalic acid can result in a more hydrophobic surface while adsorbed trimellitic acid and pyromellitic acid increased the surface negative charge and polarity. Finally, adsorption of NSAIDs onto goethite with/without surface-bound organic acids was well described by a free energy model, in which contributions of interactions (e.g., H-bonding and van der Waals) were evaluated.

Widely used pharmaceuticals present in the environment revealed as in vitro antagonists for human estrogen and androgen receptors

A considerable amount of scientific evidence indicates that a number of pharmaceuticals that could be detected in the environment can contribute towards the development of problems associated with human reproductive systems, as well as those of wildlife. We investigated the estrogenic and androgenic effects of select pharmaceuticals with high production volume and environmental relevance. We examined the receptor-binding activities of these pharmaceuticals in the T47D human cell line using altered secretion of cytokine CXCL12. Functional yeast-luciferase reporter gene assays were also employed to confirm the mechanism of receptor binding by estrogen and androgen. Non-steroidal anti-inflammatory drugs, namely ibuprofen, diclofenac and antiarrhythmic agent amiodarone showed strong anti-estrogenic effects in the T47D cell line. In the yeast-luciferase assay, these anti-inflammatory drugs also demonstrated anti-estrogenic potency and inhibited the E2 response in a concentration-dependent manner. Amiodarone did not exhibit any response in the yeast-luciferase assay; therefore, the endocrine disruption presumably occurred at a different level without directly involving the receptor. All the anti-inflammatory drugs considered in this study, including ketoprofen, naproxen and clofibrate, exhibited a dose-dependent antagonism towards the androgen receptor in the yeast-luciferase assays. Several other drugs, including the stimulant caffeine, did not show any response in the tests that were employed. A risk assessment analysis using 'Hazard Quotient' suggested a potential risk, especially in the cases of ibuprofen, ketoprofen, diclofenac and clofibrate. The results reveal the intrinsic endocrine disrupting nature of several pharmaceuticals and thus could contribute towards explaining a number of adverse health effects on humans and wildlife.